September 12, 2023 • 8:00am to 3:00pm
Philly Builds Bio+ 2nd Annual Symposium for Life Science Innovation and Development
The Union League of Philadelphia Lincoln Hall: 140 S Broad Street. Philadelphia, PA

Builds Bio+ Members: $299 Standard Registration:
$349
Register Now
A Special Full-Day Conference for Life Science, Design, and Real Estate Professionals
The Philly Builds Bio+ Annual Symposium plays a crucial role in strengthening the city's position as a thriving life science hub.
The Inaugural Symposium in 2022 was sold out and attended by more than 300 registrants. Over 40 speakers participated across the entire ecosystem, offering 3 keynotes and 7 panels, covering the science driving innovation and commercialization, venture capital investment, company formation and life sciences company development, among other topics.
By bringing together key stakeholders, facilitating knowledge exchange, and supporting the creation of initiatives like Philly Builds Bio+, the Symposium contributes to the continued growth and success of the life science industry in Philadelphia.
Testimonials from participants in the Inaugural Symposium:
“Looking forward to Philly Builds BIO+! Amazing inaugural event. Congratulations!”
“Great Combination of science and business! The speakers and panels were even more informative than I realized.”
“Good turnout, especially some corporate life sciences players. It was a great event and great venue!”
“The materials provided in the program guide provided excellent information for us to follow up after the event.”
8:00am – 8:30am: REGISTRATION & CONTINENTAL BREAKFAST
8:30am – 8:45am: WELCOME
- Nancy J Kelley, JD/ MPP
Nancy J Kelley + Associates, President & CEO Builds Bio+, Founding Member
- Mitchel W. Simpler
JB&B, Partner Emeritus Builds Bio+, Founding Member
8:45am – 9:00am: OPENING KEYNOTE Fostering Transformational Discovery During a Time of Immense Need and Great Change
- Jonathan A. Epstein, MD
Penn Medicine, Executive Vice Dean and Chief Scientific Officer
9:00am – 9:40am The Science Driving Innovation and Commercialization in Philadelphia's Research Institutions
This session will include a panel of scientists from Philly institutions, moderated by a leadingscientist, and will explore the recent and next generation of technologies that are emerging from
Philly institutions, driven by increasing NIH funding levels to Philadelphia institutions. The panel will also explore how science can differentiate Philadelphia from other major life science clusters such as Boston, San Francisco and the Greater NYC Metro area.
Moderator:
- Todd J. Kilbaugh, MD
The Children’s Hospital of Philadelphia Endowed Chair of Translational Science and Innovation
Confirmed Speakers:
- William Peranteu, MD
Children’s Hospital of Philadelphia Attending Fetal Surgeon, Division of General, Thoracic and Fetal Surgery
- Misun Hwang, MD, MS
Children’s Hospital of Philadelphia Radiologist, Director of Neonatal Imaging
- Michael Flynn
Sonnest (Drexel inventors + UPenn Medicine) Principal Electrast Engineer
9:40am – 10:20am The Intersection of Science and Technology Accelerating Innovation and Breakthroughs
This session will include a panel of innovators focusing on new technologies driving innovation and commercialization. The panels would include technology experts and will explore the recent and next generation of tools, technologies and techniques
that are emerging from institutions across the Greater Philly area.
Moderator:
- Kathleen Brunner
Acumen Analytics, President
Confirmed Speakers:
- Eric Heil
Medical Excellence Capital, Managing Partner
- Sima Singadia Kulkarni
Duane Morris LLP, Special Counsel: Patents, Trademarks, Copyrights, Licensing
- Sangeeta Bardhan Cook, PhD, MBA
Fox Chase Cancer Center, Chief Innovation Officer Temple University Health System, SVP of Strategy and Business Development
- Ben Dibling
Penn Center for Innovation, Deputy Managing Director
10:20am – 10:40am: BREAK
10:40am – 11:20am The Philly Life Science Continuum: Fueling the Advancement of Science
This panel will focus on the different elements necessary for the growth and development of life sciences, beginning with institutional research to fuel discovery, incubators/accelerators to house startups, venture capital to make them grow and real
estate to furnish housing at every stage of a company’s life cycle.
Moderator:
- Louis P. Kassa, III, MPA
Baruch S. Blumberg Institute and PA Biotechnology Center Chief Executive Officer
Confirmed Speakers:
- Matthew Burkhardt
B+labs, Director
- Lorenzo Pellegrini, PhD
Hatch Biofund, Managing Partner
- Jeffrey DeVuono,
Life Sciences, Brandywine Realty Trust Executive Vice President, Senior Managing Director
- Jesse Johnson
Serna BIO, Chief Technology Officer
11:20am – 11:35am The Patient Perspective: The Peter Powerhouse Foundation
The Peter Powerhouse Foundation was formed to improve the lives of children that are currently fighting childhood cancer by providing donations to pediatric cancer treatment facilities, and contributing financial support to researchers to improve
the lives of childhood cancer survivors. http://www.peterpowerhouse.org
Hear from Peter Zucca, first diagnosed with cancer at the age of 10 months and now 20 years old, tell his story and how the Peter Powerhouse Foundation was born. Jennifer Ball, current Executive Director of the Foundation, will also share how she
came to be involved in the Foundation, her family’s story and the stories of other families the Foundation is serving.
Confirmed Speakers:
- Jennifer Ball
Peter Powerhouse Foundation, Executive Director
- Peter Zucca
Peter Powerhouse Foundation, Founder
11:35am – 12:15am: Commercializing Innovations into Products: The Life Science Company Pipeline
This session will feature three or four mature life science companies, all of whom have received venture backing or are publicly traded. Speakers will discuss the unique life science real estate requirements that stem from the unique science they
are pursuing or products developed. The current regulatory and financial challenges in the life sciences market and the competitive pressures from surrounding life science clusters will also be discussed.
Moderator:
- Melina Blees
BioLabs Philadelphia, Site Director
Confirmed Speakers:
- Tracy Brala
University City Science Center, Senior Vice President, Strategy & Partnerships
- Kenneth Locke
Carisma Therapeutics, VP, Manufacturing and Supply Chain
- Doug Carr
Century Therapeutics, Senior Vice President and Head of Finance
- Mark Laurenzi
Aro Biotherapeutics Company, Chief Administrative Officer
- Jennifer Griffin
Mission Biocapital, Partner, Strategy & Investor RelationsPartner, Strategy & Investor Relations
- Eric Hacherl
Kyttaro Therapeutics, Chief Operating Officer
12:15pm – 1:00pm: LUNCH
1:00pm – 1:15pm: PHARMA KEYNOTE
- Michael Flaschen
Daiichi Sankyo, SVP, Global External Innovation
1:15pm – 1:45pm: The Art of Pharma and Biotech Deal Making
This panel will feature a group of pharma and biotech executives discussing the currently environment in the pharma market. How is the pharma and biotech deal-making environment evolving? What data and indications are Pharma looking for? How can the Biotechs best prepare? Is global M&A picking up traction? What is your preferred way to engage and at what time? Are there preferences between technology and therapeutics? Are platforms the future?
Moderator:
- Jennifer Manning, MPA, SVP
Center for Breakthrough Medicines, Global Strategic Partnerships
Confirmed Speakers:
- Colin Moran
Johnson & Johnson Innovation Center, Senior Director, Transactions, Discovery Sciences, Global Innovation Partnering Lead
- Elizabeth White
Entrepreneur and Former Pharma Executive
- More to Speakers to Come
1:45pm – 2:15pm Housing Life Science Innovation: The Navy Yard Philadelphia
The Navy Yard is one of the most successful redevelopment projects in US history and today is a thriving riverfront community in South Philadelphia, with more than 15k people + 150 companies + 20 acres of parks, dining options, public art, and a variety
of outdoor events. Today, the 2022 Navy Yard Plan charts the next 20 years of equitable growth at the Navy Yard, expecting to deliver an estimated 12,000 new jobs, 8.9 million square feet of new mixed-use development, and $6B of new investment.
Big or small, global or startup, the Navy Yard is a community of people and companies working alongside each other in an environment that is flexible, customizable, and often unconventional.
This panel will showcase several of the Navy Yard’s leading edge life science and biotech companies.
Moderator:
- Nelson Way
Ensemble, Director Leasing and Development
Confirmed Speakers/Projects:
- Ben Pascal
Invisible Sentinel, Co-Founder and Chief Business Officer
- John Lunger
Adaptimmune Therapeutics plc, Chief Patient Supply Officer
- Sumit Verma
Iovance Biotherapeutics, Senior Vice President, Global Strategic Manufacturing
- David Chang
WuXi App Tech (Advanced Therapies Group), President and Chief Technology Officer
2:15pm – 2:30pm: KEYNOTE Workforce Development: Ensuring Economic Opportunity in Life Science
- Tia Lyles-Williams, DSc
Goffman Bougard, Chief Executive Officer LucasPye BIO, Founder & CEO HelaPlex, Founder & CEO
2:30pm – 3:00pm Workforce Development: Ensuring Social Equity in Life Sciences
Philadelphia's life sciences industry is experiencing remarkable growth and expansion, but a key factor to maintaining this preeminence is a skilled and well-prepared workforce. Workforce solutions are being developed on multiple fronts in and around
Philadelphia. We've gathered a diverse set of success stories that highlight the achievements in our area and examine how other biotech hubs have tackled similar issues. Through the lens of lessons learned, we'll share these success stories and
discuss the broader context of where we need to go in the region.
Moderator:
- John Balchunas
National Institute for Innovation in Manufacturing Biopharmaceuticals, Workforce Director
Confirmed Speakers:
- Tom Piombino
Integrated Project Services, Managing Director, Americas
- David Zuzga
The Wistar Institute, Associate Dean of Biomedical Studies
- Vanessa Atkins
Cheyney University, Executive Director of Strategy Partnerships
and Career Pathways, Division of Social Equity
- Phil Brooks
University City Science Center, Director of STEM Workforce Partnerships
3:00pm – 4:00pm: RECEPTION


|